Neurosoft Bioelectronics
Geneva
About Neurosoft Bioelectronics
Neurosoft Bioelectronics is developing next-generation soft implantable electrodes to interface with the nervous system. Neural implants are medical devices made of electrodes that can record or stimulate the brain, spinal cord, or peripheral nerves to monitor or treat patients suffering from neurological disorders. However, current clinical devices are too stiff compared to the soft tissues of the body, which limits benefits for patients. At Neurosoft Bioelectronics, we have developed a new generation of soft and conformable implantable electrodes that seamlessly interface with the nervous tissues and can improve clinical outcomes for patients.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $3.2M
- Funding stage: Seed
- Last round: Seed (Sep 2025)
- Website: neurosoft-bio.com
- Phone: +41788761469
Industries & Categories
Health Care, Medical, Medical Device, Neuroscience
Social Profiles
Canonical: https://fsome.com/organization/neurosoft-bioelectronics-83182 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.